Key Takeaways
- USTR Greer outlines a new "replacement tariff" strategy, maintaining existing China deals while signaling potential 15% tariff hikes for other nations and new investigations into excess industrial capacity.
- Saudi Arabia is reportedly preparing a contingency plan to surge oil exports and production in the event of a U.S. strike on Iran, as OPEC+ considers a 137,000 bpd output increase for April.
- Novo Nordisk (NVO) has entered a strategic partnership with Vivtex worth up to $2.1 billion to develop oral versions of traditionally injectable biologic drugs for obesity and diabetes.
- TJX Companies (TJX) reported a Q4 sales beat of $17.74 billion, though the retailer issued cautious Q1 guidance despite announcing a massive $2.5B to $2.75B stock buyback plan.
- German Chancellor Friedrich Merz announced that China is set to order up to 120 Airbus aircraft, even as he warned that the quadrupled trade deficit with Beijing since 2020 is "not healthy."
USTR Signals Shift in Global Trade Enforcement
U.S. Trade Representative (USTR) Greer detailed a complex shift in American trade policy on Wednesday, stating the U.S. intends to stick to previous China trade deals while aggressively targeting excess capacity. Greer noted that new trade investigations will focus on forced labor in supply chains and industrial overcapacity, particularly regarding China and Indonesia.
The USTR is also engaging in high-stakes negotiations with Canada and Mexico to avoid economic disruption under the USMCA framework. Greer emphasized that the U.S. is seeking to reshore production and is open to Canadian ideas, with a formal meeting with Canadian counterparts scheduled in Washington in the coming weeks. Market participants are closely watching these developments as "replacement tariffs" are introduced to align with existing trade agreements.
Energy Markets Brace for Geopolitical Volatility
OPEC+ delegates are reportedly preparing to discuss a modest supply hike of 137,000 barrels per day (bpd) for April during their March 1 meeting. This move comes as Saudi Arabia readies a significant contingency plan to increase short-term output and exports should a U.S. military strike on Iran occur. The energy sector remains on edge as supply-side adjustments are weighed against escalating Middle East tensions.
In Russia, the government is considering tighter fiscal rules as the 2026 budget takes shape. TASS reports that the share of oil and gas revenue in the 2026 Russian budget is expected to fall below 20%. This shift suggests a move toward diversifying state revenue streams amid ongoing international sanctions and volatile energy prices.
Corporate Highlights: Novo Nordisk and TJX Results
Novo Nordisk (NVO) has expanded its reach in the metabolic disease market through a licensing deal with Vivtex. The collaboration aims to convert injectable medicines into oral formats, with Vivtex eligible for $2.1 billion in milestone payments and royalties. Novo Nordisk will take full responsibility for the manufacturing and commercialization of any resulting products for diabetes and obesity.
Retail giant TJX Companies (TJX) delivered a strong Q4 2025 performance, reporting net sales of $17.74 billion, surpassing the $17.4 billion estimate. However, the company’s Q1 EPS guidance of $0.97 to $0.99 fell short of the $1.02 analyst estimate. Despite the soft outlook, TJX plans to return significant value to shareholders through a $2.5 billion to $2.75 billion buyback program in the coming fiscal year.
European Diplomacy and Monetary Policy Divergence
German Chancellor Friedrich Merz highlighted a major win for European industry, announcing that China will order as many as 120 Airbus aircraft. While seeking "orderly market access" and "fair competition," Merz expressed concern over the trade deficit with China, which has quadrupled since 2020. Simultaneously, the German Foreign Office is pressuring Iran to stop supporting Hamas, Hezbollah, and the Houthis ahead of upcoming talks in Geneva.
On the monetary front, Bank of England (BoE) policymaker Megan Greene suggested a growing divergence between U.K. and U.S. central bank paths. Greene stated there is a "strong case" for the BoE to do the "exactly opposite" of the U.S. Federal Reserve. This potential policy split highlights the differing inflationary pressures and economic recovery speeds across the Atlantic.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.